IP Library Assignment 060638/0353
Patent Assignment
Reel/Frame 060638/0353

Security Interest

Recorded: 2022-07-13 Pages: 19
Assignor
Assignee
TD BANK, N.A.
1701 ROUTE 70 EAST, CHERRY HILL, NEW JERSEY, 08034
Covered Properties (46)
Novel Cell-Based Assay for Determining Mtor Activity
Application: 16/413,658 →
Publication: US 2019/0263875
Novel Cell-Based Assay for Determining Activity in the Retinoblastoma Pathway
Application: 17/502,217 →
Publication: US 2022/0073935
Polypeptides That Bound to Il-23 Receptor and Inhibit Binding of Il-23 and Cell Signaling Thereof
Patent: 49,026 →
Application: 15/727,360 →
Compositions and Methods for Detecting Cryptococcus Neoformans
Patent: 7,989,186 →
Application: 12/214,317 →
Publication: US 2009/0246767
Method for Determining Azole Resistance in Candida Glabrata
Patent: 8,021,846 →
Application: 12/381,492 →
Publication: US 2009/0305274
Methods and compositions related thereto for detecting and identifying distinct species of nucleic acids from causative agents
Patent: 8,932,832 →
Application: 13/199,380 →
Publication: US 2012/0064509
Novel Polypeptides That Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof
Patent: 9,169,292 →
Application: 13/771,305 →
Publication: US 2013/0172272
Anaplasma Translocated Substrate-1 (Ats-1) and Sero-detection of Anaplasma phagocytophilum
Patent: 9,134,324 →
Application: 13/888,438 →
Publication: US 2013/0295656
Novel Polypeptides That Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof
Patent: 9,605,027 →
Application: 14/922,630 →
Publication: US 2016/0039878
Methods and Compositions for Detecting Serotypes of Chlamydia Trachomatis Capable of Causing Lymphogranuloma Venereum
Patent: 8,956,814 →
Application: 13/658,207 →
Publication: US 2013/0288238
Method of Determining Susceptibility of a Tumor Cell to a Chemotherapeutic Agent: Novel Use of Herpes Simplex Virus
Patent: 8,778,331 →
Application: 12/459,332 →
Publication: US 2009/0325146
Babesia Microti Genomic Clones Containing Novel Antigens Useful in the Diagnosis of Babesiosis
Patent: 8,388,981 →
Application: 13/440,106 →
Publication: US 2012/0202227
Methods and Compositions for Detecting and Identifying Species of Candida
Patent: 9,267,179 →
Application: 13/935,599 →
Publication: US 2013/0309683
Novel Recombinant 15-Kda Polypeptide and Use of Same in Detecting Human Infection with Bartonella Henselae
Patent: 8,268,569 →
Application: 12/462,647 →
Publication: US 2010/0209936
Oligonucleotides Useful in Methods for Detecting and Characterizing Aspergillus fumigatus
Patent: 9,145,593 →
Application: 13/461,122 →
Publication: US 2013/0230848
Single Nucleotide Polymorphisms and Use of Same Predicting Male- Specific Prenatal Loss
Patent: 8,394,587 →
Application: 12/386,106 →
Publication: US 2010/0081135
Integrated Method for Collection and Maintenance of Detectability of a Plurality of Microbiological Agents in a Single Clinical Sample and for Handling a Plurality of Samples for Reporting a Sum of Diagnostic Results for Each Sample
Patent: 9,464,310 →
Application: 11/343,822 →
Publication: US 2007/0042355
Metronidazole Resistance in Trichomonas Vaginalis and Single Nucleotide Polymorphisms
Patent: 9,593,384 →
Application: 14/258,339 →
Publication: US 2014/0377749
Novel Repressor on Ifn-Lambda Promoter and Sirna Against ZEB1 and Blimp-1 to Increase Ifn-Lambda Gene Activity
Patent: 9,163,238 →
Application: 14/324,717 →
Publication: US 2014/0350072
A Method of Enhancing Mir-185 Expression to Reduce Low Density Lipoprotein/Cholesterol Accumulation in a Cell
Patent: 9,243,250 →
Application: 13/919,141 →
Publication: US 2013/0337459
Novel Repressor on Ifn-Lambda Promoter and Sirna Against GATA1, EVI1, and Crx to Alter Ifn-Lambda Gene Activity
Patent: 9,506,066 →
Application: 14/557,623 →
Publication: US 2015/0167001
Detection of a Specific Dek Isoform as a Urine-Based Biomarker for Bladder Cancer
Patent: 8,741,582 →
Application: 13/317,531 →
Publication: US 2012/0196305
Compositions and Methods for Detecting Atopobium Vaginae
Patent: 7,745,595 →
Application: 11/502,694 →
Publication: US 2008/0038726
Antibiotic resistance profile for Neisseria gonorrhoeae and use of same in diagnosis and treatment of gonorrhea
Patent: 9,297,048 →
Application: 13/134,252 →
Publication: US 2012/0071336
Novel haplotype tagging single nucleotide polymorphisms and use of same to predict childhood lymphoblastic leukemia
Patent: 9,212,395 →
Application: 12/658,269 →
Publication: US 2011/0086346
SiRNA TARGETING ETS1 AND ELK1 AND METHOD OF USING SAME IN THE INHIBITION OF CIP2A GENE IN CANCER TREATMENT
Patent: 9,139,829 →
Application: 13/776,878 →
Publication: US 2013/0225657
Compositions and Methods for Detecting Borrelia Afzelii
Patent: 8,206,930 →
Application: 13/199,093 →
Publication: US 2012/0122092
Ex-Vivo Treatment of Peripheral Plasmacytoid Dendritic Cells with Ifn-Lambda
Patent: 8,282,964 →
Application: 12/592,635 →
Publication: US 2011/0268707
Detection of Penicillin Tolerance in Group B Streptococcus: Single Nucleotide Polymorphisms in Penicillin Binding Protein 4
Patent: 8,247,170 →
Application: 12/454,408 →
Publication: US 2010/0028884
Antibodies Specific to Antigens of Bartonella Henselae and Use of These Antigens in Immunoassays
Patent: 8,101,367 →
Application: 12/592,373 →
Publication: US 2010/0298155
Splice Variants of Human Il-23 Receptor (Il-23R) Mrna and Use of a DELTA9 Isoform in Predicting Inflammatory Bowel Diseases
Patent: 8,404,824 →
Application: 13/438,456 →
Publication: US 2012/0245325
Ex-Vivo Treatment of T-Cells with Ifn-Lambda
Patent: 8,771,666 →
Application: 13/713,457 →
Publication: US 2014/0050700
Detecting Dna Methylation of BCL2, CDKN2A and NID2 Genes to Predict Bladder Cancer in Humans
Patent: 9,096,905 →
Application: 13/773,834 →
Publication: US 2013/0224738
Novel Polypeptides That Bound to Il-23 Receptor and Inhibit Binding of Il-23 and Cell Signaling Thereof
Patent: 8,946,150 →
Application: 13/523,286 →
Publication: US 2013/0029907
Recombinant Fragments and Synthetic Peptides of 17-Kda Polypeptide Useful in Detecting Bartonella Henselae
Patent: 8,283,439 →
Application: 12/462,602 →
Publication: US 2012/0058495
Type Iv Secretion System Proteins in Sero-Detection of Anaplasma Phagocytophilum
Patent: 8,338,190 →
Application: 13/561,587 →
Publication: US 2012/0288882
Protein Fragments of VIRB10 and Sero-Detection of Anaplasma Phagocytophilum
Patent: 8,389,678 →
Application: 13/418,567 →
Publication: US 2012/0183979
Anti-Sense Oligonucleotides Targeted Against Exon 9 of Il-23R-Alpha Gene and Method of Using Same to Induce Exon Skipping and to Treat Inflammatory Bowel Diseases
Patent: 9,868,776 →
Application: 14/918,657 →
Publication: US 2016/0115218
Quantitation and Profiling of Vaginal Microflora
Patent: 9,970,060 →
Application: 13/682,071 →
Publication: US 2013/0316922
Method of Determining Types I, II, III, IV or V or Methicillin-resistant Staphylococcus aureus (MRSA) in a Biological Sample
Application: 14/217,606 →
Publication: US 2014/0303072
METHODS AND REAGENTS THAT SPECIFICALLY DETECT, DISTINGUISH AND QUANTIFY IFN-LAMBDA2 mRNA FROM IFN-LAMBDA3 mRNA IN HUMANS
Application: 15/252,555 →
Publication: US 2017/0009307
Pme-1 as a Biomarker to Predict and Diagnose an Increased Risk of Endometrial Cancer and Gene Silencing of Pme-1 to Inhibit Epithelial to Mesenchymal Transition
Application: 15/487,548 →
Publication: US 2017/0226520
Recombinant Soluble Truncated Il-23 Receptor (Il-23R) Capable of Inhibiting Il-23R-Mediated Cell Signaling
Application: 13/065,878 →
Publication: US 2012/0071422
Single Nucleotide Polymorphisms and Community-Associated Methicillin-Resistant Staphylococcus aureus
Application: 16/281,141 →
Publication: US 2019/0177772
ELISA Detection of Urine DEK to Predict and Diagnose Bladder Cancer in Humans
Application: 15/656,082 →
Publication: US 2018/0011097
Novel Cell Based Assay
Application: 16/267,653 →
Publication: US 2019/0153547
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 13, 2006
From: ADELSON, MARTIN E.; MORDECHAI, ELI.
To: MEDICAL DIAGNOSTIC LABORATORIES LLC
Reel/Frame 017558/0222 →
Assignment of Assignor's Interest Jul 31, 2009
From: GYGAX, SCOTT E.; VERMITSKY, JOHN-PAUL; CHADWICK, SEAN G.; SELF, MATTHEW J.
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 023036/0148 →
Assignment of Assignor's Interest Aug 13, 2009
From: BLAHO, JOHN
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 023086/0009 →
Assignment of Assignor's Interest Nov 16, 2009
From: DORAK, MEHMET TEVFIK; UCISIK-AKKAYA, ESMA; DAVIS, CHARRONNE; DO, THUY NGOC
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 023533/0055 →
Assignment of Assignor's Interest Nov 18, 2009
From: FEOLA, MELANIE; ADELSON, MARTIN; MORDECHAI, ELI; ENTWISTLE, JOHN
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 023563/0047 →
Assignment of Assignor's Interest Aug 6, 2015
From: GALLAGHER, GRANT; YU, RAYMOND; BRAZAITIS, JONATHAN
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 036266/0274 →
Assignment of Assignor's Interest Aug 7, 2015
From: ADELSON, MARTIN; MORDECHAI, ELI
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 036274/0433 →
Security Interest Mar 1, 2016
From: MEDICAL DIAGNOTIC LABORATORIES, L.L.C.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 037963/0744 →
Security Interest Apr 27, 2018
From: MEDICAL DIAGNOSTIC LABORATORIES, L.L.C.
To: TD BANK, N.A.
Reel/Frame 046031/0381 →
Release of Security Interest Jun 12, 2018
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: MEDICAL DIAGNOSTIC LABORATORIES L. L. C.
Reel/Frame 046354/0817 →
Assignment of Assignor's Interest Oct 11, 2022
From: GALLAGHER, GRANT; YU, RAYMOND; BRAZAITIS, JONATHAN
To: MEDICAL DIAGNOSTICS LABORATORIES, LLC
Reel/Frame 061383/0084 →
Assignment of Assignor's Interest Apr 28, 2023
From: NARYSHKINA, TATYANA
To: MEDICAL DIAGNOSTIC LABORATORIES, LLC
Reel/Frame 063474/0872 →